发明申请
US20080161350A1 USE OF QUINOLINE DERIVATIVES WITH ANTI-INTEGRASE EFFECT AND APPLICATIONS THEREOF
审中-公开
喹诺酮衍生物与抗整合效应的应用及其应用
- 专利标题： USE OF QUINOLINE DERIVATIVES WITH ANTI-INTEGRASE EFFECT AND APPLICATIONS THEREOF
- 专利标题（中）： 喹诺酮衍生物与抗整合效应的应用及其应用
-
申请号： US12042628申请日： 2008-03-05
-
公开(公告)号： US20080161350A1公开(公告)日： 2008-07-03
- 发明人: Aurelia Mousnier , Catherine Dargemont , Sabine Bonnenfant , Herve Leh , Jean-Francois Mouscadet , Fatima Zouhiri , Jean D'Angelo , Didier Desmaele
- 申请人： Aurelia Mousnier , Catherine Dargemont , Sabine Bonnenfant , Herve Leh , Jean-Francois Mouscadet , Fatima Zouhiri , Jean D'Angelo , Didier Desmaele
- 专利权人： Bioalliance Pharma SA,INSTITUT GUSTAVE ROUSSY,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.),INSERM,UNIVERSITE DE PARIS 11-PARIS SUD
- 当前专利权人： Bioalliance Pharma SA,INSTITUT GUSTAVE ROUSSY,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.),INSERM,UNIVERSITE DE PARIS 11-PARIS SUD
- 优先权： FR0206126 20020517
- 主分类号： A61K31/47
- IPC分类号： A61K31/47 ; A61P31/12
摘要：
The invention relates to the use of 8-hydroxyquinoline 7-carboxylic acid derivatives in order to produce integrase inhibiting medicaments, capable of blocking viral replication in the stages preceding integration, and if appropriate, at the level of this integration stage, these medicaments being usable for the treatment of retroviral pathologies, in particular for the treatment of AIDS.
信息查询
